Live Company Group (LON:LVCG), His Excellency Mr. Bernard Fautrier, Vice-President and Chief Executive Officer of the Foundation and David Ciclitira, Chairman of the Company, today announced..
CentralNic Group Plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss its latest acquisition ‘Globehosting’. Ben explains who Globehosting are, how the company fits with CNIC,..
1PM PLC (LON:OPM) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins Directorstalk. Mark talks about the recent article “give credit where..
Greene King Plc (LON:GNK) will make the following trading statement for the 18 weeks to 2nd September 2018. The positive momentum in Pub Company continued through..
Altus Strategies Plc (LON:ALS & TSX-V: ALTS) CEO Steve Poulton talks to DirectorsTalk about a Letter of Intent with Raptor in Morocco. Steve provides us with..
AstraZeneca Plc (LON:AZN) and its partner Amgen Inc. (Amgen) announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in..
Gresham House Plc, (LON:GHE) the specialist alternative asset manager, has announced today that, with immediate effect, Canaccord Genuity Limited has been appointed as the Group’s Nominated..
ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company today announced a corporate update. Key highlights: · Lupuzor™ o Agreement signed to enter Lupuzor™ into..
